🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: DISKUS DPI

Found 25 matching trials

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD

This is a randomized, multi-center, active-controlled, repeated measures de...

Status

Completed

Location

3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa

Start Date

2016-04

Trial ID

NCT02757209

Treatments Being Tested

Spiromax (budesonide/formoterol)Turbohaler (budesonide/formoterol)Diskus(50mcg salmeterol &250/500 mcg fluticasone propionate)

Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This randomized, cross over study aims to find out the benefits of deliveri...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-09-20

Trial ID

NCT03227445

Treatments Being Tested

ELLIPTA placebo DPI DISKUS placebo DPI HandiHaler placebo DPI Inhaler preference questionnaires

Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

PHASE1

GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-12-12

Trial ID

NCT00279019

Treatments Being Tested

GSK233705 Tiotropium Placebo

Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)

N/A

Primary objective: Evaluation of the safety of Seretide discus administrati...

Status

Completed

Location

Multiple Locations

Start Date

2004-06

Trial ID

NCT00662805

Treatments Being Tested

Salmeterol/Fluticasone propionate

Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

N/A

The main purpose of the study is to assess the burden of illness for, COPD ...

Status

Completed

Location

GSK Investigational Site

Start Date

2018-05-31

Trial ID

NCT03543176

Treatments Being Tested

UMEC/VI FLUT/SAL CAT mMRC Ellipta Diskus

Dose Finding Study of CHF 4226 for Treating Patients With COPD

PHASE2

The purpose of this study is to identify the optimal once-daily dose of CHF...

Status

Completed

Location

Clopton Clinic

Start Date

2006-10

Trial ID

NCT00605891

Treatments Being Tested

carmoterol (CHF 4226)carmoterol (CHF 4226)carmoterol (CHF 4226)salmeterol placebo

A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

COPD is characterized by an airflow limitation, which is not fully reversib...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-06-16

Trial ID

NCT03034915

Treatments Being Tested

UMEC/VI 62.5/25 mcg via ELLIPTA UMEC 62.5 mcg via ELLIPTA Salmeterol 50 mcg via DISKUS Placebo via ELLIPTA Placebo via DISKUS

Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol

PHASE2

This study investigated the effect of exercise and high-dose salbutamol on ...

Status

Completed

Location

Novartis Investigative site

Start Date

2007-08

Trial ID

NCT00531050

Treatments Being Tested

Indacaterol Placebo Salmeterol

Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

This will be a non-blinded feasibility (pilot) study comparing triple thera...

Status

Terminated

Location

Wake Forest Baptist Health

Start Date

2017-10-03

Trial ID

NCT03219866

Treatments Being Tested

Nebulizers Dry Powder Inhaler Brovana Pulmicort Atrovent Advair Diskus Spiriva HandiHaler

Previous Next